Last updated: March 13, 2017
Sponsor: Yeh
Overall Status: Completed
Phase
2/3
Condition
Inflammation
Diabetic Neuropathy
Diabetes Prevention
Treatment
N/AClinical Study ID
NCT02622672
CS2-15095
Ages 20-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The diagnostic criteria for type 2 diabetes were defined as a glycohemoglobin (A1C) ≧ 6.5%, a fasting glucose ≧ 7.0 mmol/L or a 2-h plasma glucose ≧ 200 mmol/L during anoral glucose tolerance test (OGTT), as well as the use of anti-hyperglycemic drugs.
Exclusion
Exclusion Criteria:
pregnant or lactation women.
patients with liver or renal disease
Antioxidant dietary supplements user.
patients under warfarin therapy.
patients with hypoglycemia (fasting glucose < 60 mg/dL) or hyperlipidemia (fastingtriglyceride ≧ 500 mg/dL)
Study Design
Total Participants: 50
Study Start date:
January 04, 2016
Estimated Completion Date:
March 01, 2017